Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
Marcus Järås(Brigham and Women's Hospital), Benjamin L. Ebert(Broad Institute)
Cited by 93
Related Papers
Ribosomopathies: human disorders of ribosome dysfunction
|Blood|2010|797
Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells
|Blood|2010|398
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells
|Journal of Clinical Investigation|2022|62
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
|Blood Advances|2017|47
Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders
|bioRxiv (Cold Spring Harbor Laboratory)|2023|45